EMH logo

Emerald Health Therapeutics, Inc. Stock Price

CNSX:EMH Community·CA$7.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

EMH Share Price Performance

CA$0
0.00 (0.00%)
CA$0
0.00 (0.00%)
Price CA$0

EMH Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

3 Risks
0 Rewards

Emerald Health Therapeutics, Inc. Key Details

CA$7.1m

Revenue

CA$12.7m

Cost of Revenue

-CA$5.5m

Gross Profit

CA$22.6m

Other Expenses

-CA$28.2m

Earnings

Last Reported Earnings
Jun 30, 2022
Next Reporting Earnings
n/a
-0.13
-77.71%
-395.33%
0%
View Full Analysis

About EMH

Founded
n/a
Employees
111
CEO
n/a
WebsiteView website
emeraldhealth.ca

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. As of November 10, 2022, Emerald Health Therapeutics, Inc. operates as a subsidiary of Skye Bioscience, Inc.

Recent EMH News & Updates

Recent updates

No updates